<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Venous and arterial thromboses occur in patients with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease and are associated with significant morbidity and mortality </plain></SENT>
<SENT sid="1" pm="."><plain>Studies on a possible association between the occurrence of <z:mp ids='MP_0005048'>thrombosis</z:mp> and <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> in patients with this disease have been controversial </plain></SENT>
<SENT sid="2" pm="."><plain>OBJECTIVE: To determine the prevalence of the most common <z:hpo ids='HP_0100724'>thrombophilias</z:hpo> and <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidaemia</z:e> in patients with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease with and without <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Blood samples from 107 patients with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease who had or did not have <z:mp ids='MP_0005048'>thrombosis</z:mp> were analysed for factor V Leiden, prothrombin G20210A polymorphism, <z:chebi fb="0" ids="25297">methylenetetrahydrofolate</z:chebi> reductase (MTHFR) C677T polymorphism, factor VIII level, <z:chebi fb="0" ids="17230">homocysteine</z:chebi> and C reactive protein concentrations, <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidaemia</z:e>, and plasma glucosylceramide </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: There was no difference between patients with and without <z:mp ids='MP_0005048'>thrombosis</z:mp> in the prevalence of prothrombin G20210A polymorphism, factor V Leiden, homozygous MTHFR C677T, or plasma concentrations of <z:chebi fb="0" ids="17230">homocysteine</z:chebi>, C reactive protein, or glucosylceramide </plain></SENT>
<SENT sid="5" pm="."><plain>In contrast, patients with <z:mp ids='MP_0005048'>thrombosis</z:mp> were found to have significantly higher mean levels of factor VIII, total cholesterol, <z:chebi fb="4" ids="17855">triglycerides</z:chebi>, <z:chebi fb="0" ids="47773">VLDL cholesterol</z:chebi>, and <z:chebi fb="0" ids="39015">apolipoproteins</z:chebi> B-100, C-II, and C-III than those without <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>Multistepwise logistic regression analysis showed that <z:chebi fb="0" ids="17855">triglyceride</z:chebi> concentration was the best marker associated with <z:mp ids='MP_0005048'>thrombosis</z:mp> (p = 0.008), with an estimated odds ratio of 1.58 (95% confidence interval, 1.09 to 2.30) for a difference of 40 mg/dl </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: <z:hpo ids='HP_0100724'>Thrombophilia</z:hpo> does not seem to play a major role in the tendency to <z:mp ids='MP_0005048'>thrombosis</z:mp> in <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease </plain></SENT>
<SENT sid="8" pm="."><plain>However, <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidaemia</z:e>, predominantly hypertriglyceridaemia, might be a risk factor </plain></SENT>
</text></document>